Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Haim Biran"'
Autor:
Tamar Peretz, Hadas Gantz-Sorotsky, Marina Perelman, Beatrice Uziely, Victoria Doviner, Haim Biran, Nir Peled, Hovav Nechushtan, Amir Onn, Benjamin Nisman, Jair Bar
Publikováno v:
British Journal of Cancer
Background: Progastrin-releasing peptide (ProGRP) is a potential marker for small-cell lung cancer (SCLC) in serum; however, it may be more stable in plasma. We investigated a new plasma assay (ProGRPp) and its usefulness in diagnosing and monitoring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b501e62e25f84763910e8c8e5601e6a8
https://doi.org/10.1038/bjc.2016.7
https://doi.org/10.1038/bjc.2016.7
Autor:
Maya Gottfried, Amir Onn, Lior Soussan-Gutman, Addie Dvir, Dekel Shlomi, Hovav Nechushtan, Haim Biran, Jair Bar, Maya Ilouze, Nir Peled
Publikováno v:
Journal of Cancer Therapy. :54-58
Background: In the last decade, the search for gene mutations in lung cancer has been constantly growing. EGFR, KRAS mutations and, recently, the EML4-ALK fusion can guide the selection of treatment for patients who carry a specific mutation. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::264742f08c2f740129591ea0fa7f987f
https://doi.org/10.4236/jct.2013.48a009
https://doi.org/10.4236/jct.2013.48a009
Autor:
Efraim Idelevich, Sofia Man, Nana Ben Zvi, Michael Dinerman, Noa Ben Baruch, Adi Shani, Rivka L. Katsenelson, Natalie Karminsky, Haim Biran
Publikováno v:
Acta Oncologica. 46:324-329
More than two-thirds of patients with gastric cancer present with metastatic disease and their curative options are limited. This phase II study assessed the efficacy and tolerability of cisplatin, epirubicin, tegafur-uracil (UFT) and leucovorin in p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d66d2f832a52112060d92e440f8a856
https://doi.org/10.1080/02841860600871079
https://doi.org/10.1080/02841860600871079
Publikováno v:
Tumor Biology. 27:8-16
Chromogranin A (CGA), Pro-gastrin-releasing peptide (ProGRP) and neuron-specific enolase (NSE) are known as immunohistochemical tissue markers closely associated with neuroendocrine differentiation in non-small-cell lung carcinoma (NSCLC). The aim of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4639f68a9bac36688bf9c029b6be5a
https://doi.org/10.1159/000090151
https://doi.org/10.1159/000090151
Autor:
Haim Biran, Dana Botser, Jair Bar, Damien Urban, Rossie Navon, Tal Sella, Shiri Tenenbaum, Amir Onn
Publikováno v:
Lung cancer (Amsterdam, Netherlands). 88(1)
Objective Cancer patients in developed countries increasingly express a preference for more detailed information and involvement in decisions about their care. However, data is sparse and conflicting on preferences of ethnic minorities and immigrants
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::336a427226f75103813118a97d8009e1
https://pubmed.ncbi.nlm.nih.gov/25682317
https://pubmed.ncbi.nlm.nih.gov/25682317
Autor:
Rivka Katsnelson, Arnold Cyjon, Maya Gips, Ofer Merimsky, Maya Gottfried, Amir Onn, Nili Peylan-Ramu, Nir Peled, Hadas Gantz Sorotsky, Haim Biran, Shoshana Keren Rosenberg, Hovav Nechushtan, Dov Flex, Jair Bar, Julia Dudnik
Publikováno v:
Lung. 192(5)
Testing tumor samples for the presence of a mutation in the epithelial growth factor receptor (EGFR) gene is recommended for advanced non-squamous non-small cell lung cancer (NSCLC) patients. We aimed to collect data about common practice among Medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5093ca375a3f3b080d91f575e4fdf18
https://pubmed.ncbi.nlm.nih.gov/24964874
https://pubmed.ncbi.nlm.nih.gov/24964874
Publikováno v:
British Journal of Cancer
Prognostic implication of serum cytokeratin 19 fragments (CYFRA 21-1) was explored in 60 advanced NSCLC patients, whereas in 45 patients assessable for serological response aor=35% CYFRA 21-1 decline after two chemotherapy cycles was strongly associa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56c4e0a2d9181d982c69a28a0201bcad
https://doi.org/10.1038/sj.bjc.6604157
https://doi.org/10.1038/sj.bjc.6604157
Publikováno v:
Therapeutic Drug Monitoring. 17:203-206
Summary The pharmacokinetics of intravenously administrated cisplatin (CDDP) were studied in a patient with meduloblastoma receiving regular hemodialysis for chronic renal failure. The patient received four CDDP infusions of 25 mg/m2 in two courses a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8404754917b2b2a46943da45549e9e51
https://doi.org/10.1097/00007691-199504000-00018
https://doi.org/10.1097/00007691-199504000-00018
Publikováno v:
Cancer. 73:168-175
Paraneoplastic nervous system syndromes are being identified with increasing frequency because of greater physician awareness and the availability of serodiagnostic tests for some syndromes. Frequently, paraneoplastic syndromes develop in the setting
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::994fb63ba9c8e26a41bb7039594291e6
https://doi.org/10.1002/1097-0142(19940101)73:1<168::aid-cncr2820730129>3.0.co
https://doi.org/10.1002/1097-0142(19940101)73:1<168::aid-cncr2820730129>3.0.co
Publikováno v:
Anticancer research. 29(11)
To investigate the diagnostic and prognostic significance of pro-gastrin-releasing peptide (ProGRP) in non-small cell (NSCLC) and small cell lung cancer (SCLC) and compare this marker with other known serum markers in lung cancer.Serum levels of ProG
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6695d809a748d732a1647168bcca7c5c
https://pubmed.ncbi.nlm.nih.gov/20032442
https://pubmed.ncbi.nlm.nih.gov/20032442